Australian Pharmaceuticals & Biotech Upcoming Dividends

Vita Life Sciences

Market Cap: AU$136.3m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

CSL

Market Cap: AU$95.8b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.